Delivery Order SPE2DB22D1103-SPE2DB24FTQJ3
Award Date
8/19/24
Potential Completion Date
8/20/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $16,095.56 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. The contract has a period of performance through December 20, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. The contract has a ceiling value of $1,354.52 and a period of performance through April 10, 2024. This delivery order contract is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $3,164.73 and an ultimate completion date of March 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a $3,048.54 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a medical product, with a completion date of June 26, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $11,676.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,358.18, is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 24, 2024. This award is not associated with a set-aside designation. AmerisourceBergen holds a...
This is a $1,697.81 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract provides for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, to support federal government medical requirements. The contract has a period of performance through May 8, 2024 and was not set aside for any specific business category. AmerisourceBergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,450.25 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 12, 2024, with a completion date of August 13, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This is a delivery order awarded under an Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,213.11 firm fixed-price contract is to provide the drug YUPELRI 175 MCG/3 ML SOLUTION UD 3ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 19, 2024. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,389.28, is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a medical product, with a period of performance through June 13, 2024. The contract has a firm fixed price pricing type and is not associated with any set-aside designation, indicating open...